欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/H/0646/001
药品名称ProHance 0.5 mmol/mL, Solution for injection in vials
活性成分
    • gadoteridol 0.5 mmol/ml
剂型Solution for injection
上市许可持有人Bracco Imaging France 7, place Copemic - Courcouronnes -91023 Evry Cedex karine.vienne@bracco.com
参考成员国 - 产品名称France (FR)
ProHance 0.5 mmol/mL, solution injectable en flacon
互认成员国 - 产品名称
    • Portugal (PT)
    • Greece (GR)
    • Latvia (LV)
      Prohance 0,5 mmol/ml šķīdums injekcijām
    • Lithuania (LT)
      ProHance 0,5 mmol/ml injekcinis tirpalas
    • Estonia (EE)
      PROHANCE
    • Hungary (HU)
      PROHANCE 0,5 mmol/ml oldatos injekció
    • Romania (RO)
      ProHance 0,5 mmol/ml soluție injectabilă
    • Slovenia (SI)
    • Croatia (HR)
      ProHance 0,5 mmol/ml otopina za injekciju
许可日期2019/04/15
最近更新日期2024/04/11
药物ATC编码
    • V08CA04 gadoteridol
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase